Cronos Group (Cron) Crashed 10% Dragging Cannabis Stocks Following Cannacord Downgraded

After Cronos Group reported fourth-quarter losses of C$11.Eight million ($8.Eight million) and Cannacord analysts Matt Bottomley and Bobby Burleson downgraded the inventory to sell from maintain, its inventory fell to as little as $17.72 per share on Wednesday.


The inventory of the Cronos Group went up 82% year-to-date to $25.10 per share in February and traders had been anticipating final quarter’s income to return round C$10. four million because it obtained C$2. four billion or US$1. Eight billion funding from tobacco big Altria Inc. However, the precise gross sales got here out a lot decrease than what the analysts had been anticipating and amounted to solely C$5.6 million, that put a giant query market on the lucrativeness of the Canadian leisure pot market.

“Cronos has seen its share price almost double as one of only two licensed producers to receive a significant equity investment from a global strategic partner,” mentioned Bottomley and Burleson in regards to the firm.

The downgrade was largely predicted as different main Cannabis corporations did comparatively nicely final quarter in comparison with their measurement and market valuation. “We note that CRON’s first full quarter of recreational sales fell well behind its large-cap peer group, which reported net revenues that ranged from C$21M to C$83M for the same period,” mentioned Cannacord in a observe to its brokerage purchasers.

Furthermore, GMP Securities analyst Martin Landry famous that Cronos’ stockpile of pot has decreased to C$10.6 million by the tip of 2018. Cronos Group solely had C$1. 6 million value of hashish that was able to ship and the provision bottleneck will possible have an hostile impact on its income targets within the coming quarters as nicely.

The downgrade of Cronos Dragged Most Cannabis Stocks Down


The downgrade of the Cronos Group by Cannacord had a widespread impact on virtually all Cannabis shares and consequently, the Horizons Marijuana Life Sciences ETF additionally fell sharply on Wednesday. At the time of reporting, Horizons Marijuana Life Sciences fell 3.9% to $21.55.

Horizons Marijuana Life Sciences ETF tries to copy the efficiency of the North American Marijuana Index that tracks the main hashish shares working within the United States and Canada. Hence, it appeared that the fiscal efficiency of Cronos Group is perhaps affecting the complete Cannabis business and traders ought to take observe about how the intrinsic valuation of different corporations as nicely.

Bottom Line

The downgrade of the Cronos Group definitely made traders nervous. While the monetary efficiency of the Cronos Group justifies the preliminary response of the market to a sure extent, the actual fact stays that rising Cannabis business in Canada and the United States nonetheless represents some of the profitable funding alternatives in 2019.

Besides Cronos Group, most main publicly traded Cannabis corporations appear on observe and their inventory valuation to be at par with progress prospects of the business.

As the saying goes “the time to buy is when there’s blood in the streets,” and it appears the analysts from Cannacord has introduced traders with ample blood on the street.

The put up Cronos Group (Cron) Crashed 10% Dragging Cannabis Stocks Following Cannacord Downgraded appeared first on CryptoPotato.

We will be happy to hear your thoughts

      Leave a reply